.Novo Nordisk is actually continuing its push in to hereditary medicines, accepting to compensate Na...
.Innovent Biologics has made the scenario that its checkpoint inhibitor-cytokine fusion protein has ...
.A phase 3 trial of Daiichi Sankyo and also Merck & Co.'s HER3-directed antibody-drug conjugate (...
.Five months after Rakovina Therapies turned towards artificial intelligence, the cancer-focused bio...
.Ascendis Pharma has become a potential danger to BioMarin's Voxzogo, stating period 3 development c...
.Though Alkeus Pharmaceuticals' dental eye ailment property neglected to substantially reduce geogra...
.Along with a triad of biotechs hitting the Nasdaq on Friday, it was actually quick and easy to miss...
.Invulnerable checkpoint inhibitors are the superheroes of cancer therapy. Medicines like Bristol My...
.Invite to this week's Chutes & Ladders, our roundup of substantial leadership hirings, firings a...
.Regeneron is back with long-term consequence for its own LAG-3 prevention as well as PD-1 inhibitor...